- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Orphazyme is a biotechnology business based in the US. Orphazyme shares (ORPH) are listed on the NASDAQ and all prices are listed in US Dollars. Orphazyme employs 180 staff and has a trailing 12-month revenue of around $13.2 million.
Our top picks for where to buy Orphazyme A/S stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Orphazyme stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ORPH. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Orphazyme stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 5 of 5
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Orphazyme stock price (NASDAQ: ORPH)
Use our graph to track the performance of ORPH stocks over time.Orphazyme shares at a glance
Information last updated 2024-01-24.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $1.28 |
| 200-day moving average | $3.31 |
| Wall St. target price | $1.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.83 |
Is it a good time to buy Orphazyme stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Orphazyme financials
| Revenue TTM | $13.2 million |
|---|---|
| Gross profit TTM | $0 |
| Return on assets TTM | -88.16% |
| Return on equity TTM | -251.34% |
| Profit margin | 0% |
| Book value | $4.77 |
| Market Capitalization | $37.3 million |
TTM: trailing 12 months
Orphazyme share dividends
We're not expecting Orphazyme to pay a dividend over the next 12 months.
You may also wish to consider:
Orphazyme share price volatility
Over the last 12 months, Orphazyme's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Orphazyme's is 0.8023. This would suggest that Orphazyme's shares are less volatile than average (for this exchange).
To put Orphazyme's beta into context you can compare it against those of similar companies.
- Biogen (BIIB.US): -0.061
- Regeneron Pharmaceuticals (REGN.US): 0.142
- Moderna (MRNA.US): 1.69
Orphazyme overview
Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company focuses on the amplification of heat-shock proteins to develop and commercialize therapeutics for diseases caused by protein misfolding and aggregation, and lysosomal dysfunction, including lysosomal storage and neuromuscular degenerative diseases. Its lead candidate is the Arimoclomol, which is in clinical development for four orphan diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, Inclusion Body Myositis, and Gaucher disease. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark. .
Frequently asked questions
What percentage of Orphazyme is owned by institutions?Currently 3.802% of Orphazyme shares are held by institutions. How many people work for Orphazyme?
Latest data suggests 180 work at Orphazyme. When does the fiscal year end for Orphazyme?
Orphazyme's fiscal year ends in December. Where is Orphazyme based?
Orphazyme's address is: Ole Maaløes Vej 3, Copenhagen, Denmark, 2200 What is Orphazyme's ISIN number?
Orphazyme's international securities identification number is: US6873051022 What is Orphazyme's CUSIP number?
Orphazyme's Committee on Uniform Securities Identification Procedures number is: 687303107
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question